Shenzhen Fuwei City Investment Co., Ltd., established on 2008-04-07, Business scope includes general business items:Invest in business(Specific projects will be reported separately);Aquatic products,Sales of primary agricultural products and domestic trade(Does not contain franchise,Exclusive control,Monopoly);Engaged in the import and export of goods and technology(Except for those expressly prohibited by the state and specially permitted);aquaculture,vegetable,fruit planting(branch office only,Separate application for branch business license);agriculture,Technology Development in Fisheries.,The licensing program is:

iNtRON Biotechnology, Inc. engages in the development of super-bacteria treatment, antibiotics alternatives, bio new drug, molecular diagnostics and artificial blood. Its products include anti-bacterial agents, identification kits, research reagents and kits. The company was founded on January 18, 1999 and is headquartered in Seongnam-si, South Korea.

Lufeng Fuwei City Planting and Breeding Base Co., Ltd., established on 2007-12-14, The scope of business includes crop cultivation,Aquaculture,agriculture,Fishery Technology Promotion,Photovoltaic electricity production,Sales,Photovoltaic power project development,Information Consulting;Aquatic products,Sales of agricultural and sideline products,buy,Domestic Trade,Import and export,Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

CJ Corporation (Korean: 씨제이㈜) is a South Korean conglomerate holding company headquartered in Seoul. It comprises numerous businesses in various industries of food and food service, pharmaceutics and biotechnology, entertainment and media, home shopping and logistics. CJ Group was originally a branch of Samsung until it separated in the 1990s.

Shanghai Xingyao Medical Technology Development Co., Ltd. engages in the research and development, production, marketing, sale, and service of in vitro diagnostic reagents and equipment. The company was founded on May 30, 1994 and is headquartered in Shanghai, China.

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

Biotron Ltd. operates as a clinical stage biotechnology company. It engages in developing and commercializing a novel small molecule approach that treats serious viral disease. The firm's technology targets viroporin proteins, which enables the pathogenicity of a number of viruses including hepatitis C, HIV-1, Dengue, Zika, Influenza and respiratory syncytial virus. Its proprietary bacterial cell-based screening platform enables rapid screening for target viroporin proteins. The company was founded in February 1999 and is headquartered in North Ryde, Australia.